What Is the HALT Fentanyl Act?

The HALT Fentanyl Act, formally known as the Halt All Lethal Trafficking of Fentanyl Act, is a significant legislative proposal. It aims to combat the escalating issue of fentanyl-related substances in the U.S..

It has the potential to bring about substantial changes in drug policies, particularly those related to fentanyl and its analogues.

This bill suggests major revisions to the federal classification, regulation, and prosecution of offenses related to fentanyl and its analogues.

This legislation would equip government agencies with enhanced tools to combat fentanyl-related drug crimes and improve regulatory procedures for scientific research.

In essence, the HALT Fentanyl Act is a strategic response to the fentanyl crisis in the United States. This crisis, characterized by a rapid surge in overdoses and deaths linked to fentanyl, necessitates legislative action.

The bill proposes a permanent designation of fentanyl-related substances (FRS) as Schedule I drugs under the Controlled Substances Act, equipping law enforcement with essential tools to combat illegal trafficking and prosecute those involved in distributing these deadly drugs.

Quantity Thresholds

Offenses involving FRS will be subject to the same quantity thresholds and penalties as those involving fentanyl analogues, including possible mandatory minimum prison sentences.

The bill aims to support research on Schedule I substances, including FRS, by establishing a new registration process and simplifying administrative steps for research funded by agencies such as HHS or VA, or conducted under an FDA IND exemption. Let's examine what this bill would accomplish.

Key Fentanyl Act Takeaways

The HALT Fentanyl Act aims to address the fentanyl crisis by raising penalties for trafficking fentanyl-related substances and facilitating research to understand better and counteract their effects, providing hope for a safer future.
By permanently implementing FRS, the bill aims to equip law enforcement with essential tools to fight illegal trafficking and prosecute those involved in distributing these deadly drugs.
Proponents of the bill are driven by a shared goal: to reduce the increasing overdose deaths associated with synthetic opioids such as fentanyl and FRS. The Act, with its focus on penalties and research facilitation, offers a beacon of hope for a healthier, safer future.
Streamlining the research process aims to facilitate studies on FRS and other Schedule I substances, potentially enabling the development of treatments for addiction and overdose. This could greatly enhance our understanding and management of opioid addiction, providing hope for those impacted by this crisis.
Critics claim that the bill focuses too much on punishment and overlooks important public health issues like addiction treatment and rehabilitation related to the opioid crisis.
Critics also raise concerns about whether tougher penalties will substantially decrease drug-related deaths, pointing to previous cases where harsher sentencing laws failed to produce the intended outcomes.
Some are concerned that permanently scheduling all FRS as Schedule I may hinder research into potentially beneficial substances within that category.
Federal law, under 21 U.S.C. § 952, prohibits the unauthorized importation of controlled substances and certain precursor chemicals.

Permanent Schedule I Designation

The main aspect of the HALT Fentanyl Act is that it will permanently categorize fentanyl-related substances as Schedule I drugs under the Controlled Substances Act (CSA).

Schedule I represents the most stringent drug classification under federal law. Substances here are deemed to have a high potential for abuse, no accepted medical use, and are unsafe for medical supervision.

Since 2018, fentanyl-related substances have been temporarily listed under Schedule I via a series of administrative orders and legislative extensions.

The HALT Fentanyl Act aims to establish this classification as permanent. By formalizing it, the government guarantees that all fentanyl analogues—whether studied or not—are under the strictest regulatory oversight.

For individuals charged with offenses involving fentanyl-related substances, this classification indicates that possession, distribution, manufacturing, or trafficking of these substances will attract the harshest penalties under federal law.

Main Penalties Stipulated by the Act

The HALT Fentanyl Act specifies that crimes involving fentanyl-related substances will be handled the same as those involving fentanyl analogues. Consequently, mandatory minimum sentences based on particular quantities of these substances will be enforced.

Offenses with 100 grams or more of a fentanyl-related substance result in a mandatory minimum prison sentence of 10 years.
Even small amounts can lead to substantial prison sentences, increasing with the quantity and involvement in distribution.

This alignment with fentanyl analogue penalties not only strengthens the government's capacity to prosecute individuals accused of fentanyl-related offenses but also serves as a deterrent.

The severe sentencing aims to incapacitate those already convicted and deter potential traffickers, contributing to the prevention of future crimes.

Changes to Research Regulations

The HALT Fentanyl Act responds to scientists' and researchers' concerns regarding access to fentanyl-related substances for legitimate research. It implements new measures to simplify research regulations, striking a balance between law enforcement interests and the necessity of scientific investigation into substances that may have therapeutic or medical benefits.

Registration: Researchers can now register a single time to manage multiple related sites, preventing the need for repeated processes for similar tasks.
Inspections: The act exempts some cases from new inspection requirements, helping compliant researchers avoid delays.
Manufacturing: Researchers with registration are allowed to produce limited amounts of Schedule I substances for research without needing extra licenses.

Strengthening Prosecutorial Tools

A key feature of the HALT Fentanyl Act is its enhancement of prosecutors' ability to charge and convict under federal drug laws. The act clarifies multiple provisions of the CSA to make the legal framework for fentanyl-related substances as thorough as possible.

Broaden Definition: The act follows the precedent established in United States v. McCray (2018), where butyryl fentanyl was considered an analogue of fentanyl. This indicates that substances chemically similar to fentanyl, even if not specifically listed as controlled, can still be prosecuted as Schedule I drugs.
Uniform Treatment: By classifying all fentanyl-related substances as Schedule I, the act streamlines prosecutorial efforts and closes potential loopholes that could allow certain substances to avoid strict regulation.

What are the Consequences for Defendants?

If you're under investigation or facing criminal charges for drug offenses involving fentanyl, you probably already face the possibility of significant prison time if found guilty. Even with the temporary classifications in place, you could still be subject to some of the strictest penalties in the CSA.

If enacted into law, the HALT Fentanyl Act will facilitate prosecutors in convicting individuals and imposing strict penalties and mandatory minimums.

Your best chance to avoid severe consequences is to hire a knowledgeable federal criminal defense attorney experienced in drug offenses. A skilled attorney can:

Evidence: Identify gaps, inconsistencies, and errors in the prosecution's evidence, including unlawful searches or improperly handled evidence.
Challenge Classification: Check whether the substances are properly classified as fentanyl-related or Schedule I drugs according to federal law.
Negotiate: Work with prosecutors to decrease charges or penalties by offering cooperation or mitigating factors.
Mandatory Sentencing: Argue against harsh mandatory sentences by highlighting mitigating circumstances or advocating for leniency.
Defense Strategy: Create a defense by arguing against intent, demonstrating a lack of knowledge, or questioning connections to fentanyl-related substances.

For further details, contact our federal criminal defense law firm, Eisner Gorin LLP, in Los Angeles, CA.

Fentanyl Act